In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual ...

An oral melanocortin-4 receptor agonist conferred significant BMI reductions among adolescents and adults with hypothalamic ...

EXCLUSIVE: Top doctor Dr Kim Boyd says its programmes are needed 'more than ever' despite the boom in weight loss drugs.

And fourth, focus on changing the environment, not just people. We must shift the focus to the systems and structures that ...

For many people, weight loss is often framed as a matter of willpower – a simple equation of exercising regularly and eating a healthy diet. But, Dr. Sindhura Bandaru, an ...

Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity - ...

Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has ...

Indian pharmaceutical giant, Cipla, is preparing to venture into the weight management sector in India, according to its MD and global CEO Umang Vohra.

India's top endocrinologist, Dr Ambrish Mithal has come out with a very well timed and a much needed explainer on the new crop of weight loss drugs that have flooded the market. Entitled, "The Weight ...